Clinical and economic impact of inhaled corticosteroid withdrawal in Spanish COPD patients treated with triple therapy
V. Neches (Madrid, Spain), L. Vallejo-Aparicio (Madrid, Spain), A. Ismaila (Collegeville, United States of America), A. Sicras-Mainar (Barcelona, Spain), A. Sicras-Navarro (Barcelona, Spain), C. González (Valencia, Spain), R. Cuervo (Madrid, Spain), S. Shukla (Collegeville, United States of America), M. Garcia-Peñuela (Madrid, Spain)
Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Neches (Madrid, Spain), L. Vallejo-Aparicio (Madrid, Spain), A. Ismaila (Collegeville, United States of America), A. Sicras-Mainar (Barcelona, Spain), A. Sicras-Navarro (Barcelona, Spain), C. González (Valencia, Spain), R. Cuervo (Madrid, Spain), S. Shukla (Collegeville, United States of America), M. Garcia-Peñuela (Madrid, Spain). Clinical and economic impact of inhaled corticosteroid withdrawal in Spanish COPD patients treated with triple therapy. 800
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: